Veterinary Molecular Diagnostics Market Report 2025

This veterinary molecular diagnostics market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The veterinary molecular diagnostics market size has grown rapidly in recent years. It will grow from $0.63 billion in 2024 to $0.7 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to the high prevalence of zoonotic and foodborne diseases, rising adoption of multiple testing panels, growing consolidation in the veterinary diagnostics industry, increased animal health spending, and rising demand for animal-derived food.

The veterinary molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.01 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising adoption of companion animals, increasing adoption of pet insurance, rising pet population, increasing animal healthcare expenditure, and increasing demand for animal diagnostic tests. Major trends in the forecast period include technological advancements in veterinary molecular diagnostic technologies, advanced laboratory devices, technological advancements such as PCR, next-generation sequencing (NGS), and microarray technological advancements.

The high prevalence of zoonotic diseases is expected to drive growth in the veterinary molecular diagnostics market. Zoonotic diseases, which can be transmitted between animals and humans, are caused by bacteria, viruses, parasites, or fungi. Examples include rabies, Lyme disease, salmonellosis, and toxoplasmosis. Factors contributing to the prevalence of these diseases include deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and increased human mobility. Veterinary molecular diagnostics play a crucial role by enabling early detection of zoonotic diseases in animals, which helps prevent their transmission to humans and improves disease management through rapid and accurate pathogen identification. For example, a February 2024 report from the Government of the United Kingdom revealed that Lyme disease cases in England increased from 273 in the fourth quarter of 2022 to 335 in the same period of 2023. This rising prevalence of zoonotic diseases is fueling demand for veterinary molecular diagnostics.

Leading companies in the veterinary molecular diagnostics market are focusing on automation and scalability in diagnostic technologies, such as high-volume testing machines. These advanced devices are designed to process large numbers of samples efficiently, enhancing diagnostic accuracy and speed. For instance, in June 2023, Iowa State University's Veterinary Diagnostic Laboratory (VDL) introduced the SmartChip, a state-of-the-art molecular diagnostic testing device featuring quantitative polymerase chain reaction (qPCR) technology. The SmartChip can handle over 5,000 samples on a plate the size of a postage stamp and is paired with a 384-sample system that includes automated handling features. Utilizing microfluidic technology, the SmartChip identifies targets in samples using a volume 100 times smaller than that of the VDL’s standard 96-well machines.

In June 2022, R-Biopharm AG, a biotechnology company based in Germany, acquired AusDiagnostics. This acquisition expands R-Biopharm AG's molecular diagnostics portfolio, enhances its role as a comprehensive system supplier, and fosters growth in the clinical diagnostics market. AusDiagnostics, an Australian company, specializes in molecular biology multiplex diagnostics solutions.

Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.

North America was the largest region in the Veterinary Molecular Diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Veterinary molecular diagnostics involves the use of molecular biology techniques to identify and diagnose animal diseases at the genetic or molecular level. These diagnostics detect specific pathogens (such as bacteria, viruses, or parasites), genetic mutations, or biomarkers that signal disease, assisting veterinarians in making precise diagnoses and treatment plans.

The main products in veterinary molecular diagnostics include kits, reagents, and instruments. Kits and reagents are crucial for conducting various diagnostic tests on animal samples in laboratories and industrial settings, providing accurate and reliable results necessary for effective treatment and management of diseases. These diagnostics are applicable to both companion animals and livestock, addressing conditions such as infectious and genetic diseases. The primary users of these products are diagnostic laboratories, veterinary clinics, veterinary hospitals, and similar facilities.

The veterinary molecular diagnostics market research report is one of a series of new reports that provides veterinary molecular diagnostics market statistics, including veterinary molecular diagnostics industry global market size, regional shares, competitors with an veterinary molecular diagnostics market share, detailed veterinary molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary molecular diagnostics industry. This veterinary molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary molecular diagnostics market consists of revenues earned by entities by providing services such as diagnostic testing services, surveillance testing, genetic testing, toxicology, and biocompatibility testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary molecular diagnostics market also includes sales of immunoassay kits, diagnostic software, and next-generation sequencing (NGS) systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.